FMD and NMD were measured using the UNEXEF18G before and after 4-week treatment of rosuvastatin ( 5 mg/day ) with or without atenolol ( 25 mg/day ) in 44 hypercholesterolemic patients ( 708 years old , LDL-C > 140 mg/dL ) with hypertension .